Trial Profile
Importance of intrahepatic tumour control as prognostic factor in sorafenib-treated patients with hepatocellular carcinoma and extrahepatic metastases
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Dec 2015
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 23 Dec 2015 New trial record